Breakpoint zone of bcr in chronic myelogenous leukemia does not correlate with disease phase or prognosis
- 1 November 1988
- journal article
- research article
- Published by Elsevier in Cancer Genetics and Cytogenetics
- Vol. 36 (1), 117-122
- https://doi.org/10.1016/0165-4608(88)90081-7
Abstract
No abstract availableThis publication has 21 references indexed in Scilit:
- Undetectable bcr‐abl rearrangements in some CML patients are due to a deletion mutation in the bcr geneAmerican Journal of Hematology, 1988
- CML patients in blast crisis have breakpoints localized to a specific region of the BCRBlood, 1987
- Identification of molecular variants of p210bcr-abl in chronic myelogenous leukemiaBlood, 1987
- bcr-abl RNA in patients with chronic myelogenous leukemiaBlood, 1987
- A technique for radiolabeling DNA restriction endonuclease fragments to high specific activityAnalytical Biochemistry, 1983
- Detection of specific sequences among DNA fragments separated by gel electrophoresisJournal of Molecular Biology, 1975
- Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosomeBlood, 1975
- SEPARATION OF HELA CELLS BY COLLOIDAL SILICA DENSITY GRADIENT CENTRIFUGATIONThe Journal of cell biology, 1972
- A generalized Wilcoxon test for comparing arbitrarily singly-censored samplesBiometrika, 1965
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958